TradeTrade
Jump to any asset 849 assets, updated daily

As of September 16, 2026, IQVIA Holdings Inc. (IQV) trades at $269.67. CleaRank Financial AI rates it Buy with a fair value of $278.00, 3.1% above the current price. Wall Street's consensus target is $278.00 across 21 analysts. RSI at 61 is in neutral territory, and the price is above its 50-day average of $237.67.

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. NYSE

$269.67 4.000 (1.51%)
At close: Sep 15, 4:00 PM EDT
AI Analyst Consensus
Buy
75 / 100
IQVIA Holdings Inc. (IQV) is currently trading at $269.67, above its 50-day and 200-day moving averages ($237.67 and $203.06), indicating positive price momentum. The stock's RSI is at 60.77, signaling bullish momentum, and its MACD is positive at 7.82. Wall Street analysts maintain a consensus 'Buy' rating with a median price target of $278, suggesting a modest upside of 3.1% from current levels. The company operates within the Healthcare sector, specifically in Diagnostics & Research, and its fundamentals show a profit margin of 8.10% and a return on equity of 22.82%. While the price-to-sales ratio of 2.54 is below the sector median of 3.7, the P/E ratio of 32.56 is slightly above the sector median of 31.9. The company's debt-to-equity ratio stands at 2.58, which is higher than the sector average, warranting attention for balance sheet risk. Recent earnings have shown mixed results, with a significant EPS surprise of 81.82% in the quarter to June 2026, though the stock reacted negatively.

IQV Price Analysis

Market Metrics

Open
$263.17
Day Range
$262.95 to $272.35
Prev Close
$265.67
Volume
1.44M
52-Week Range
$154.50 to $272.35
Market Cap
$44.39B

Peer Benchmarking

Valuation vs Sector (Healthcare)

Performance vs XLV

Sector Position Analysis
Valuation is broadly in line with sector peers (2% difference), suggesting fair market pricing relative to industry standards.

IQV Financial Performance

Revenue vs. Earnings

Annual

Quarterly

Earnings Reality Check

Analysis: In the last 2 quarters, IQV beat estimates 2 times. However, the stock fell 2 times the next day. This suggests positive news is often "priced in" or investors are selling the news.

IQV Analysis

Company's Health 4/5
12-Month Analyst Target +3.09% Upside
Median of 21 analysts (12-month)
$278.00
AI Technical Analysis Buy
IQVIA Holdings Inc. (IQV) is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), indicating an uptrend. The Relative Strength Index (RSI) is at 60.77, classified as bullish, suggesting strong upward momentum. The Moving Average Convergence Divergence (MACD) is positive at 7.82, further reinforcing the bullish sentiment. Key support levels are indicated by the 50-day SMA at $237.67 and the 20-day EMA at $257.90. Resistance is suggested by the current price and potentially higher levels based on analyst targets. Volume has been slightly above average recently, supporting the current price action. The overall chart structure points towards continued upward potential, provided these technical levels hold.
ProTips
  • Monitor insider selling activity closely, as over $52.6 million in sales have been reported recently, which could signal management concerns.
  • The stock is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), indicating positive short-to-medium term momentum, but watch for any breaches of these support levels.
  • Given the higher debt-to-equity ratio of 2.58 compared to sector peers, investors should assess the company's debt servicing capabilities and interest rate sensitivity.
Key Catalysts
Bullish Positive EPS Surprises in Recent Quarters

IQVIA Holdings Inc. (IQV) has demonstrated an ability to beat analyst EPS estimates, including a significant 81.82% surprise in the quarter to June 2026, suggesting operational efficiency.

Source: Company Earnings Reports
Bearish Significant Insider Selling Activity

Over $52.6 million in insider sales have been recorded recently, indicating potential concerns from management regarding the stock's current valuation or future prospects.

Source: Insider Transaction Filings
Neutral Continued Revenue Growth Projections

Analysts forecast continued revenue growth for IQVIA Holdings Inc. (IQV), with next-year revenue growth estimated at 6.00%, supporting the company's market position.

Source: Analyst Estimates
Bullish Strong Technical Momentum

IQVIA Holdings Inc. (IQV) is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), with a bullish RSI of 60.77 and positive MACD, suggesting favorable price action.

Source: Technical Analysis Data
Market Outlook
IQVIA Holdings Inc. (IQV) is positioned for continued growth, with Wall Street analysts projecting next-year EPS growth of 11.5% and revenue growth of 6.00%. The median analyst price target of $278 suggests a modest upside from the current price, aligning with the stock's bullish technical indicators including trading above key moving averages and positive RSI and MACD readings. The company's strong return on equity of 22.82% further supports a positive outlook. Potential catalysts for upside include continued strong execution in its diagnostics and research segment and successful integration of any new business developments. Conversely, risks such as the high debt-to-equity ratio of 2.58 and the substantial recent insider selling could weigh on the stock. Any failure to meet elevated market expectations, as hinted at by the market's reaction to recent earnings, could lead to a downside correction.

Key Statistics

Market Cap 44.39B
P/E Ratio 32.56
EPS (TTM) 8.04
Dividend Yield 0.00%
52 Week High 272.35
52 Week Low 154.50
IQVIA Holdings Inc. (IQV) presents a mixed valuation picture with a P/E ratio of 32.56, which is slightly above the Healthcare sector median of 31.9. However, its price-to-sales ratio of 2.54 is below the sector median of 3.7, suggesting potential value on a revenue basis. The company demonstrates strong profitability with an 8.10% net profit margin and a strong 22.82% return on equity, significantly outperforming the sector's median ROE of 6.9%. Growth efficiency is supported by a next-year EPS growth estimate of 11.5%. The company's balance sheet shows a debt-to-equity ratio of 2.58, which is higher than the sector average, indicating a greater reliance on debt financing. This leverage, combined with the P/E ratio, suggests that investors are pricing in significant future growth, which needs to be consistently delivered to justify the current valuation.

Earnings & Growth Analysis

IQVIA Holdings Inc. (IQV) reported a significant EPS surprise of 81.82% in the quarter to June 2026, with actual EPS of -$0.02 against an estimate of -$0.11, although the stock saw a slight decline of 0.03% on the news. Prior to this, the quarter to December 2025 also showed an EPS beat of 13.64%. The company's revenue growth was reported at 8.7%, and forward estimates suggest continued growth with next-year revenue growth projected at 6.00%.

Key Risks

A primary risk for IQVIA Holdings Inc. (IQV) stems from significant insider selling, with over $52.6 million in sales reported recently, indicating potential concerns among management regarding future performance or valuation. The company's debt-to-equity ratio of 2.58 is notably higher than the sector average, increasing financial risk, especially if interest rates rise or earnings falter. Also, while recent earnings have shown positive surprises, the stock's negative reaction to the latest earnings report suggests that market expectations may be high and sensitive to any deviations.

Technical Indicators i

RSI (14) 60.77
MACD 7.82
SMA 50 237.67
SMA 200 203.06
Technical Rating Bullish
RSI
Bullish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($237.67) above the 200-day SMA ($203.06), price action is firmly bullish above key moving averages.

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.42
Moderate correlation
Nasdaq 100 (QQQ) +0.31
Weak correlation
Bitcoin (BTC) +0.22
Weak correlation
Gold (XAU) +0.02
Weak correlation
Check Custom Correlation

How does any other asset move with IQV? One year of daily closes, Pearson correlation.

Try

IQV Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Long entry pick an entry style

Conservative
$264.28
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$269.67
Buy at current price
Higher risk, immediate entry

Risk Management

STOP LOSS
$250.11
MAX LOSS
-5.4%
Volatility-Adjusted Stop Loss
Calculated based on RSI (60.8) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$277.49
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$290.70
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$303.92
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Disclaimer
This AI-generated trade plan for IQV is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 16, 2026.

Growth of $10,000

A $10,000 investment in IQV in September 2016 would be worth about $34,882 today, compared with about $35,497 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IQV today could grow to about $26,337 by 2036 in the base case, with a bull case near $97,464 and a bear case around $7,117. Projections are statistical simulations, not guarantees.

IQV Stock Price Prediction: 2030

CleaRank's simulation projects a price near $397 for IQV by 2030 in the base case, from $270 today (1.5x over 4 years). The downside path ends near $174. These are outcomes of a Monte Carlo simulation run on IQV's historical return distribution, not price targets, and they assume no dividends are reinvested.

IQV simulated price paths by year
Year Downside (10th pct) Base case Upside (90th pct)
2027 $196 $297 $449
2028 $182 $327 $588
2029 $176 $361 $738
2030 $174 $397 $909
2031 $173 $438 $1,104
2032 $175 $482 $1,328
2033 $178 $531 $1,587
2034 $182 $585 $1,886
2035 $186 $645 $2,231
2036 $192 $710 $2,628

Method: 10,000 simulated price paths using IQV's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.

People Also Watch

IQV Insider Trading Analysis

Source: SEC Form 4
Bought
None
No open-market buys
Sold
$52.6M
11 Transactions
Insiders
14
Active Traders
$ Avg Transaction
$4.8M
Large trades
Recent insider transactions in IQV
Date Insider Type Shares Value
Jun 15, 2018
CPP INVESTMENT BOARD PRIVATE HOLDINGS INC
Beneficial Owner of more than 10% of a Class of Security
Sell 9.3M $957.0M
Nov 30, 2017
CPP INVESTMENT BOARD PRIVATE HOLDINGS INC
Beneficial Owner of more than 10% of a Class of Security
Sell 7.5M $764.8M
Jun 15, 2018
TPG GROUP HOLDINGS SBS ADVISORS INC
Unknown
Sell 6.7M $691.8M
Jun 15, 2018
TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
Sell 6.7M $691.8M
Mar 8, 2019
TPG GROUP HOLDINGS SBS ADVISORS, INC.
Director
Sell 4.0M $569.5M
Nov 30, 2017
TPG GROUP HOLDINGS SBS ADVISORS INC
Director and Beneficial Owner of more than 10% of a Class of Security
Sell 5.4M $552.8M
Nov 30, 2017
TPG GROUP HOLDINGS SBS ADVISORS, INC.
Director and Beneficial Owner of more than 10% of a Class of Security
Sell 5.4M $552.8M
Feb 13, 2020
TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
Sell 3.0M $492.3M
Jul 28, 2020
TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
Sell 2.9M $464.5M
Dec 4, 2018
TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
Sell 3.6M $442.1M

Frequently Asked Questions

What is IQVIA Holdings Inc.'s stock price forecast for 2030?
IQVIA Holdings Inc.'s (IQV) stock price forecast for 2030, based on Monte Carlo simulations, projects a base case of $397.24, with a downside scenario at $173.64 and an upside scenario at $908.8. These are statistical outcomes, not guaranteed price targets.
Is IQVIA Holdings Inc. stock a buy right now?
IQVIA Holdings Inc. (IQV) is currently rated as a 'Buy' by Wall Street analysts, with a median price target of $278, suggesting a 3.1% upside from its current price of $269.67. The stock exhibits bullish technical indicators, including trading above key moving averages and a positive RSI.
What are the main risks facing IQVIA Holdings Inc.?
Key risks for IQVIA Holdings Inc. (IQV) include substantial insider selling totaling over $52.6 million, a high debt-to-equity ratio of 2.58 compared to the sector average, and potential market sensitivity to earnings results, as evidenced by the stock's reaction to recent reports.
How does IQVIA Holdings Inc. compare to its sector averages?
IQVIA Holdings Inc. (IQV) shows a P/E ratio of 32.56, slightly above the Healthcare sector median of 31.9, but its price-to-sales ratio of 2.54 is below the sector median of 3.7. The company's ROE of 22.82% significantly outperforms the sector median of 6.9%, while its debt-to-equity ratio of 2.58 is higher than the sector average.
What is the recent earnings performance of IQVIA Holdings Inc.?
IQVIA Holdings Inc. (IQV) recently reported a significant EPS surprise of 81.82% for the quarter ending June 2026. While the company has demonstrated positive EPS surprises in recent quarters, the stock experienced a minor decline following the latest earnings release.
What is the outlook for IQVIA Holdings Inc. over the next 12 months?
The outlook for IQVIA Holdings Inc. (IQV) is cautiously optimistic, supported by a 'Buy' consensus from analysts and positive technical indicators. The company is expected to continue its revenue growth trajectory, with next-year revenue growth estimated at 6.00%. However, significant insider selling and a high debt-to-equity ratio present notable risks that could impact performance.
Are there any significant institutional holders or activist investors in IQVIA Holdings Inc.?
While specific large institutional holders or activist investors are not detailed, the significant insider selling activity, totaling over $52.6 million, warrants close monitoring for any shifts in management sentiment or strategic direction.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The stock analysis, trade plans, and AI-generated signals presented for IQV are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. They do not represent actual trades made by CleaRank or its affiliates. Stock prices can be volatile and are subject to market, economic, and company-specific risks. Market data is provided "as-is" and may be delayed by 15 minutes or more. We do not guarantee the accuracy, completeness, or timeliness of any data. You should never invest money you cannot afford to lose. Past performance does not guarantee future results. Consult a qualified financial advisor before making any investment decisions. Analysis generated on September 16, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.